使用丰富-瘦的过渡程序来评估假定的抗焦虑药物
Forrest Toegel1, Cory Toegel1, James K Rowlett2
1Department of Psychological Science, Northern Michigan University, Marquette, Michigan.
The Journal of pharmacology and experimental therapeutics
|August 7, 2025
概括
一种新的富瘦过渡程序有效地评估非人类灵长类动物的潜在抗焦虑药物,而无需使用厌恶性休克. 这种方法显示了前临床药物评估的希望,通过观察行为变化来应对强化计划的变化.
科学领域:
- 行为神经科学 行为神经科学
- 药理学 药理学是指药理学的学科.
- 心理药理学 心理药理学
背景情况:
- 传统的抗焦虑药物评估依赖于像冲击这样的厌恶刺激,在非人类灵长类动物中构成实际挑战.
- 强化计划中的丰富-瘦转换会破坏操作者的行为,这种干扰是二可以改善的,这表明了潜在的替代评估方法.
研究的目的:
- 评估一种丰富-瘦的过渡程序的可行性和实用性,用于未使用冲击的潜在抗焦虑药物的临床前评估.
- 为了确定这个程序是否可以区分抗焦虑和焦虑药物效应.
主要方法:
- 成年 rhesus 子的杆按压行为在两组多重计划下得到加强,其中包括丰富 (4颗颗粒) 和瘦 (1颗粒) 组件.
- 会议包括组件 (瘦-瘦,瘦-富,富-瘦,富-富) 之间的不规则过渡,以观察行为障碍,特别是在富-瘦过渡后暂停.
- 评估了类药物 (米达佐拉姆,阿尔普拉佐拉姆),一种伊米达佐特里亚辛 (TPA-023B),吗啡和 (+) 胺对丰富瘦身暂停的作用.
主要成果:
- 富-瘦转换可靠地诱导了 rhesus 子的延长暂停行为.
- 二和TPA-023B有选择性地减少了这种暂停,与焦虑缓解效应一致.
- 吗啡和 (+) 氨基胺选择性地增加了暂停,表明焦虑类效应.
结论:
- 富瘦过渡程序是对非人类灵长类动物抗焦虑药物的临床前评估的可行和有效方法.
- 这种无冲击的范式证明了在识别潜在的焦虑解消和焦虑生成化合物的实用性,基于它们对行为干扰的调制.
相关概念视频
01:26Anxiolytic Drugs: Overview
489
Anxiolytic drugs are vital in managing anxiety disorders by effectively alleviating symptoms such as excessive fear, tachycardia, and tremors. There are several classes of anxiolytic medications, each with unique mechanisms of action and potential side effects.
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
Primary Types of Anxiolytic Drugs
1. Benzodiazepines:
Benzodiazepines bind to the GABA-A receptor in the brain, enhancing GABA's interaction. This action reduces neurotransmission, effectively blocking anxiety-associated limbic...
489
01:29Anxiolytic Drugs: Benzodiazepines and Buspirone
1.3K
Benzodiazepines are a class of anxiolytic drugs known for their rapid efficacy and high therapeutic-to-lethal dose ratio, but with a potential risk of drug dependence. These drugs are lipophilic, allowing for rapid absorption after oral administration, eventually reaching the central nervous system (CNS). Once in the CNS, benzodiazepines bind to the allosteric site of the GABAA receptor. This binding enhances the inhibitory effects of the neurotransmitter GABA. By doing so, they prevent...
1.3K
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
243
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
243
01:23Sedatives and Hypnotics: Overview
647
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
647